Log in to save to my catalogue

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary dise...

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary dise...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fb00e03d0f8641e9bbfca8c9c870db5b

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

About this item

Full title

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

Publisher

England: BioMed Central Ltd

Journal title

BMC pulmonary medicine, 2021-09, Vol.21 (1), p.301-301, Article 301

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chronic obstructive pulmonary disease (COPD) exacerbations are heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic acid (LPA) has been implicated in airway inflammation but the significance of LPA in COPD exacerbation is not known. The aim of the study was to investigate the utility of serum LPA species (LPA1...

Alternative Titles

Full title

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fb00e03d0f8641e9bbfca8c9c870db5b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fb00e03d0f8641e9bbfca8c9c870db5b

Other Identifiers

ISSN

1471-2466

E-ISSN

1471-2466

DOI

10.1186/s12890-021-01670-9

How to access this item